Intermittent Hypoxic Exposure (IHE): Protocols, Benefits, and Risks
A complete guide to intermittent hypoxic exposure protocols for athletes — what the science shows, how to design an IHE program, and the risks to know.
Intermittent Hypoxic Exposure (IHE): Protocols, Benefits, and Risks
Intermittent hypoxic exposure (IHE) offers something traditional altitude training cannot: the possibility of altitude adaptation without leaving sea level. By repeatedly exposing the body to periods of low-oxygen breathing — in sessions ranging from minutes to hours — IHE protocols attempt to trigger the same physiological machinery that makes altitude training valuable. The evidence is nuanced, the protocols vary widely, and the risks are real. This guide cuts through the noise.
What Is Intermittent Hypoxic Exposure?
IHE is a passive altitude simulation technique in which athletes breathe hypoxic gas (reduced-oxygen air) in repeated short cycles, typically at rest or during light activity. Unlike continuous altitude training — which involves living or sleeping at elevation for weeks — IHE compresses the hypoxic stimulus into discrete sessions lasting 60–90 minutes, repeated over days to weeks.
The technique gained traction in Soviet-bloc sports science programs in the 1970s–1990s, where hypoxic breathing chambers were used to prepare Olympic athletes without the logistical burden of altitude travel. Since then, commercial devices ranging from hypoxic generators to rebreather-style masks have made IHE accessible to a broader range of athletes.
IHE is distinct from:
- Intermittent Hypoxic Training (IHT): Exercise under hypoxia (IHE is passive/resting exposure)
- Live High, Train Low (LHTL): Continuous altitude living (12+ hours/day) vs. short daily IHE sessions
- Normobaric hypoxic tents: These produce continuous (sleeping) hypoxia, not intermittent
The IHE Protocol Structure
IHE protocols vary significantly in the literature, but the most commonly studied structure involves cycling between hypoxic and normoxic (normal oxygen) breathing:
Classic IHE (Pulsed Hypoxia)
- Hypoxic phase: Breathe 10–12% FiO₂ (equivalent to ~4,500–6,000 m) for 5–7 minutes
- Normoxic recovery: Breathe normal air (20.9% O₂) for 3–5 minutes
- Repetitions: 5–8 cycles per session
- Session duration: 60–90 minutes total
- Frequency: 5 sessions/week for 3–4 weeks
- Session SpO₂ target: Should drop to approximately 80–88% during hypoxic phases; this is intentional
The pulsed structure is thought to exploit the hypoxia-reoxygenation oscillation — each low-oxygen phase activates HIF-1α and EPO signaling, while the normoxic phase allows partial recovery of cellular oxygen before the next cycle.
Modified IHE for Athletes
Some practitioners use a more graduated approach:
- Week 1: FiO₂ 14–15% (simulated ~2,500–3,000 m), 60 min/day
- Week 2–3: FiO₂ 12–13% (simulated ~3,500–4,500 m), 75 min/day
- Week 4: FiO₂ 11–12% (simulated ~4,500–5,500 m), 90 min/day
This progressive approach reduces the acute stress on the cardiovascular and ventilatory systems while building adaptation tolerance.
Physiological Mechanisms: What IHE Does to the Body
Chemoreceptor Sensitization
The peripheral chemoreceptors — particularly the carotid bodies — are the primary sensors of arterial oxygen. Repeated hypoxic exposure sensitizes these sensors, improving the hypoxic ventilatory response (HVR). This means athletes who complete IHE protocols respond more robustly to real altitude when they encounter it, ventilating more aggressively and maintaining SpO₂ more effectively.
Enhanced HVR is consistently reported across IHE studies and is one of the most reliable physiological outcomes.
EPO and Erythropoiesis
Here is where IHE's evidence base becomes more mixed. EPO is secreted primarily by the kidneys in response to low PaO2 (arterial oxygen tension). For this stimulus to drive meaningful erythropoiesis (red blood cell production), the signal must be sustained — renal cells must detect hypoxia for long enough to mount a robust transcriptional response.
Short IHE sessions (5–7 minutes of hypoxia interspersed with normoxia) may not provide sufficient continuous hypoxic signal to reliably elevate EPO. A meta-analysis by Hamlin & Hellemans (2007) found that classic IHE protocols produced inconsistent and generally modest Hbmass changes compared to continuous altitude living.
Practical implication: IHE is a weaker driver of Hbmass increases than LHTL protocols. Athletes seeking significant red cell gains need longer daily hypoxic exposures — ideally sleeping in an altitude tent (continuous hypoxia for 8–10 hours) rather than relying on IHE sessions alone.
Muscular and Cardiovascular Adaptations
Where IHE does show more consistent benefit is in peripheral adaptations:
- Improved vascular function: Repeated hypoxia/reoxygenation cycles appear to stimulate nitric oxide production and improve endothelial function
- Mitochondrial adaptations: HIF-1α activation drives some degree of mitochondrial biogenesis and upregulation of oxidative enzymes
- Autonomic nervous system effects: Some studies report improved heart rate variability and parasympathetic tone after IHE protocols
These adaptations may explain why some IHE studies show performance benefits even without robust Hbmass changes — the gains come through non-hematological pathways.
Hypoxic Preconditioning
An emerging area of interest: IHE may function as a form of hypoxic preconditioning, making the body more resilient to the acute stress of real altitude. Athletes who complete IHE protocols before travel to altitude tend to acclimatize faster, with lower AMS incidence and better-maintained performance in the first week of elevation exposure.
What IHE Can (and Cannot) Achieve
Evidence-Supported Benefits
- Accelerated altitude acclimatization when used pre-altitude travel (Grade A evidence)
- Enhanced HVR and chemoreceptor sensitivity (Grade A)
- Mild improvements in aerobic capacity in some untrained-to-moderately-trained populations (Grade B)
- Possible AMS reduction when used as preconditioning (Grade B)
- Vascular and autonomic improvements (Grade B)
What IHE Is Unlikely to Do
- Produce the same Hbmass gains as 3–4 weeks of continuous LHTL at 2,200–3,000 m (insufficient cumulative hypoxic dose)
- Fully replace altitude training for elite athletes seeking structural erythropoietic adaptation
- Match the performance gains of 4-week altitude camps in head-to-head comparisons
IHE Equipment: What Athletes Are Using
Hypoxic Generators + Mask
The most common setup: a device that separates nitrogen from room air to reduce oxygen concentration, feeding hypoxic air via mask or tent. Quality devices can precisely dial FiO₂ from 9–20.9%. Brands include Hypoxico, B-Cat, and various Chinese-manufactured units.
Cost: $2,000–$8,000 for quality generators. Lower-cost units may have inaccurate FiO₂ delivery.
Altitude Simulation Masks (Resistive Breathing)
A common misconception: resistive breathing masks (the kind worn during training that restrict airflow) do not produce hypoxia. They increase breathing resistance but don't reduce FiO₂. These masks train respiratory muscles but are not IHE devices. True IHE requires actual reduction of oxygen concentration in inspired air.
Rebreather-Style Devices
Some older IHE devices use a rebreathing circuit to incrementally increase CO₂ while reducing O₂. These can produce hypoxic hypercapnia (combined low O₂/high CO₂ stress), which may engage additional chemoreceptor pathways. Less common in contemporary protocols.
Altitude Simulation at Home: Practical Setup
For athletes interested in altitude simulation without purchasing high-end equipment, there are accessible alternatives:
Option 1: Altitude tent — Provides continuous normobaric hypoxia during sleep. More practical than IHE for Hbmass goals; a tent system costs $500–$3,000. This is the recommended approach for athletes whose primary goal is erythropoiesis.
Option 2: IHE mask sessions — For hypoxic preconditioning and HVR training without a tent, a portable IHE mask system (fed from a small generator or pre-filled hypoxic air canisters) can be used during rest or light activity. Less evidence for performance gains but useful for altitude preparation.
Option 3: Commercial IHE services — Some sports medicine clinics and performance centers offer supervised IHE sessions. This is a reasonable option for athletes who want occasional sessions without equipment investment.
Risks and Safety Considerations
IHE is generally safe in healthy athletes when performed as designed, but several risks warrant attention:
SpO₂ Below 80%
During IHE sessions using 10–12% FiO₂, SpO₂ may legitimately drop to 80–85%. This is intentional — it's the stimulus. However, SpO₂ below 75% at rest is concerning and suggests excessive hypoxic dose or an underlying cardiac/pulmonary issue.
All IHE sessions should be conducted with continuous SpO₂ monitoring.
Cardiovascular Risk in Non-Athletes
IHE involves significant intermittent cardiovascular stress. In healthy, trained athletes it is well-tolerated. For individuals with undetected cardiac arrhythmias, coronary artery disease, or hypertension, IHE carries meaningful risk. Pre-participation cardiac screening is recommended.
Oxidative Stress from Hypoxia-Reoxygenation
The cycling between hypoxia and normoxia generates reactive oxygen species (ROS) at the moment of reoxygenation — a well-documented phenomenon in cardiac reperfusion research. Whether this level of oxidative stress is problematic in the context of athletic IHE is debated. Adequate antioxidant status and nutrition likely mitigate the risk.
Sleep Disruption
Unlike altitude tent sleeping, IHE sessions are typically conducted during waking hours. However, session timing matters — performing 90 minutes of hypoxic exposure in the late evening may impair sleep quality in some athletes due to elevated sympathetic arousal. Schedule sessions in the morning or early afternoon.
Contraindications
- Active respiratory infection or pneumonia
- Severe anemia (Hb < 10 g/dL)
- Known cardiac arrhythmia or uncontrolled hypertension
- Pregnancy
- Recent eye surgery (elevated IOP risk)
Designing an IHE Protocol: A Practical Template
Goal: Pre-altitude acclimatization (4 weeks before altitude travel)
| Week | FiO₂ | Session Duration | Cycles | Frequency |
|---|---|---|---|---|
| 1 | 15% (~2,500 m simulated) | 60 min | 6 × 5 min hypoxia / 4 min normoxia | 5×/week |
| 2 | 13% (~3,500 m simulated) | 75 min | 7 × 6 min / 4 min | 5×/week |
| 3 | 12% (~4,000 m simulated) | 90 min | 8 × 7 min / 4 min | 5×/week |
| 4 | 11% (~4,500 m simulated) | 90 min | 8 × 7 min / 4 min | 4×/week |
Monitor SpO₂ throughout. Target nadir of 80–86% during hypoxic phases. If SpO₂ drops below 75% or athlete reports dizziness, lightheadedness, or palpitations — stop session.
Goal: Performance enhancement without altitude travel
Use weeks 1–3 of the above protocol, combined with altitude tent sleeping at 2,500–2,800 m simulated. The combined continuous + intermittent hypoxia produces stronger EPO responses than IHE alone, while remaining logistically feasible for a sea-level athlete.
CTA: Altitude Simulation at Home
IHE and altitude tent sleeping are the most accessible forms of altitude simulation for athletes based at sea level. If you're serious about altitude adaptation without the travel, these tools work — when used with the right protocol. Subscribe to the AltitudePerformanceLab newsletter for a free IHE protocol guide, equipment comparison, and step-by-step altitude tent setup instructions — or explore our Altitude Training Plan Builder to periodize these modalities into your training year.
Grounded in: Hamlin & Hellemans (2007) IHE meta-analysis; Millet et al. (2010) hypoxic methods comparison; Bernardi et al. (2001) chemoreceptor sensitization IHE; Serebrovskaya (2002) intermittent hypoxia review; Wilber (2007) altitude training methods.